Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Objective: Distinguishing immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) from the AEs caused by chemotherapy, targeted therapy, or infection is highly difficult. This study offers new insights into evaluating the diagnosis, differential diagnostic, and prognostic...
Guardado en:
Autores principales: | Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu, Xiubao Ren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
China Anti-Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f35fc1f305e4dacbf38d508d4a1651f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DETERMINATION OF DIAGNOSTIC ACCURACY OF BIOCHEMICAL PARAMETERS (CRP, LDH & FERRITIN) IN THE DIAGNOSIS OF COVID-19 IN SUSPECTED COVID CASES
por: Tayyaba Ashiq, et al.
Publicado: (2021) -
Possible effect of decreased insulin resistance on ferritin levels after Nordic Walking training
por: Ilhan B, et al.
Publicado: (2016) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Di Wang, et al.
Publicado: (2021) -
Extraction and purification of Ferritin from liver tissue
por: R Behjati Ardakani, et al.
Publicado: (2005) -
Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
por: Parastou Paydarnia, et al.
Publicado: (2021)